mani
peptid
known
inhibit
entri
envelop
virus
cell
includ
one
peptid
success
use
clinic
drug
review
discuss
discoveri
antivir
activ
mechan
action
peptid
peptid
entri
inhibitor
discov
wide
varieti
approach
structurebas
accident
intent
ration
brute
forc
show
share
common
physic
chemic
properti
least
somewhat
hydrophob
andor
amphipath
propens
interact
membran
interfac
propos
propens
drive
share
mechan
action
mani
peptid
entri
inhibitor
involv
direct
interact
viral
cellular
membran
well
interact
complex
hydrophob
proteinlipid
interfac
expos
least
transient
viruscel
fusion
interact
simultan
membran
interfac
critic
hydrophob
surfac
hypothes
peptid
entri
inhibitor
act
chang
physic
chemistri
membran
fusion
protein
interfac
bridg
interfer
fusion
cellular
viral
membran
base
idea
propos
approach
focus
interfaci
hydrophob
put
entri
inhibitor
could
lead
effici
discoveri
novel
broadspectrum
viral
entri
inhibitor
envelop
virus
ancient
ubiquit
class
human
pathogen
infect
rate
mortal
rate
often
express
measur
percentag
entir
human
popul
class
includ
mani
wellknown
virus
influenza
human
immunodefici
hepat
c
small
pox
chicken
pox
yellow
fever
herp
measl
mani
also
includ
tropic
pathogen
signific
grow
global
public
health
concern
eg
dengu
lassa
chikungunya
virus
virus
recent
elicit
fear
novel
deadli
global
pandem
eg
avian
influenza
sar
mer
virus
virus
signific
biothreat
potenti
eg
ebola
hantavirus
rift
valley
fever
viru
virus
mention
review
discuss
discoveri
develop
character
mechan
action
peptid
inhibit
entri
envelop
virus
host
cell
past
decad
peptid
steadili
gain
import
drug
design
deliveri
increasingli
focu
shift
toward
develop
refin
techniqu
identifi
synthet
peptid
drug
candid
bioactiv
peptid
discov
use
natur
occur
peptid
ration
engin
highthroughput
screen
structurebas
design
use
sequenc
known
region
protein
factor
respons
emerg
peptid
grow
market
pharmaceut
industri
current
peptid
base
drug
market
constitut
entir
drug
market
describ
one
effect
peptid
entri
inhibitor
envelop
viru
approv
use
human
clinic
trial
mani
peptid
entri
inhibitor
envelop
virus
describ
scientif
literatur
review
discuss
surpris
observ
major
known
peptid
entri
inhibitor
discov
extraordinari
divers
approach
share
common
physic
chemistri
somewhat
hydrophob
amphipath
propens
bind
lipid
membran
hypothes
share
physic
chemistri
could
result
share
mechan
action
one
enabl
gener
approach
discoveri
broadspectrum
peptid
entri
inhibitor
envelop
virus
genom
envelop
virus
enter
cell
sequenti
multistep
process
requir
viru
bind
cell
surfac
receptor
ii
fusion
viral
membran
cellular
membran
essenti
step
occur
incomplet
understood
process
viral
fusion
protein
ie
envelop
glycoprotein
spike
protein
see
fig
mediat
tempor
spatial
coordin
close
contact
cellular
viral
membran
simultan
perturb
continu
membran
hydrophob
segment
envelop
viru
famili
event
trigger
endocytosi
surfacebound
viru
subsequ
endosom
acidif
virus
hiv
fusion
trigger
conform
chang
occur
upon
bind
cell
surfac
receptor
coreceptor
entir
depend
endosom
acidif
fusion
protein
envelop
virus
group
sever
distinct
class
base
protein
secondari
tertiari
structur
class
fusion
protein
predominantli
trimer
fold
elong
bundl
class
includ
wellknown
spike
protein
influenza
hemagglutinin
hiv
class
ii
fusion
protein
defin
elong
multidomain
rich
structur
found
exampl
flavivirus
class
ii
fusion
protein
dimer
prefus
configur
transit
trimer
state
low
phinduc
fusion
class
iii
fusion
protein
mix
structur
found
exampl
herp
virus
despit
structur
divers
fusion
protein
entri
mechan
envelop
virus
share
critic
biolog
activ
structur
signatur
fig
class
cell
surfac
bind
driven
specif
chain
domain
fusion
protein
protein
complex
distinct
domainchain
drive
fusion
viral
envelop
cellular
membran
membran
fusion
driven
larg
conform
rearrang
fusion
protein
expos
hydrophob
fusion
peptid
fusion
loop
also
simultan
present
hydrophob
sequenc
fusion
protein
catalyz
membran
fusion
fig
show
schemat
structur
repres
class
class
ii
class
iii
viral
fusion
protein
preand
postfus
state
addit
hydrophob
fusion
peptid
termin
peptid
class
protein
intern
loop
class
ii
protein
pair
fusion
loop
class
iii
fusion
protein
viral
fusion
protein
also
hydrophob
sequenc
like
interact
membran
contribut
fusion
process
exampl
mani
conserv
hydrophob
aromaticrich
domain
adjac
membranespan
helix
domain
hiv
call
membran
proxim
ectodomain
region
mper
highli
conserv
critic
function
mper
sequenc
hiv
also
epitop
one
broadli
neutral
antibodi
hiv
mper
hydrophob
amphipath
aromat
suggest
function
like
involv
membran
bind
destabil
class
viral
fusion
protein
also
intern
hydrophob
segment
includ
leucin
zipper
likemotif
lie
interfac
helic
heptad
repeat
domain
may
also
becom
expos
least
transient
conform
rearrang
drive
fusion
class
ii
fusion
protein
similar
featur
exampl
often
conserv
aromatichydrophob
juxtamembran
domain
call
stem
domain
like
mper
interact
strongli
membran
interfac
form
amphipath
helix
addit
stem
domain
class
ii
fusion
protein
hydrophob
region
like
involv
fusion
process
interestingli
arenaviru
class
ii
fusion
protein
complex
includ
call
stabl
signal
peptid
ssp
domain
conserv
requir
protein
contain
two
transmembran
helic
segment
connect
loop
domain
unlik
signal
sequenc
arenaviru
ssp
remain
stabli
insert
viral
envelop
associ
fusion
protein
complex
hydrophob
ssp
whose
function
remain
unknown
potenti
provid
addit
hydrophob
surfac
proteinmembran
interfac
aris
fusion
similarli
architectur
class
iii
fusion
protein
contain
hydrophob
patch
may
particip
fusion
although
less
known
class
iii
fusion
protein
overal
reason
hypothes
function
viral
fusion
protein
similarli
depend
exposur
multipl
hydrophob
segment
form
continu
hydrophob
surfac
bridg
viral
cellular
membran
allow
fusion
take
place
mix
lipid
two
membran
hypothesi
suggest
broadspectrum
approach
entri
inhibit
envelop
virus
may
possibl
target
physic
chemistri
hydrophob
surfac
membran
fusion
protein
expos
fusion
highlight
potenti
vulner
fusion
process
inhibit
chang
protein
structur
chang
membran
physic
properti
chang
time
protein
conform
chang
addit
antibodi
peptid
small
molecul
bind
fusion
protein
reason
viral
entri
would
seem
vulner
target
antivir
countermeasur
inde
small
molecul
inhibit
viral
fusion
entri
includ
inhibitor
influenza
arenaviru
junin
compound
function
bind
fusion
protein
inhibit
viruscel
fusion
howev
small
molecul
possibl
approach
entri
inhibit
may
ideal
suit
interact
larg
conform
fluid
interfac
hydrophob
surfac
hypothes
critic
inhibit
entri
larger
molecul
peptid
polym
interact
hydrophob
membraneprotein
interfac
may
also
well
suit
entri
inhibitor
exampl
shown
viral
fusion
peptid
hydrophob
bind
membran
inhibit
viral
entri
perhap
importantli
inhibit
occur
due
physic
chemic
interact
transient
hydrophob
proteinmembran
interfac
broadspectrum
entri
inhibit
without
rapid
select
resist
possibl
review
discuss
mani
known
peptid
entri
inhibitor
envelop
virus
show
almost
alway
hydrophob
andor
amphipath
sequenc
propens
membran
interfac
bind
hiv
retroviru
target
deplet
tcell
respons
caus
aid
global
ten
million
peopl
infect
hiv
lead
million
death
per
year
characterist
structur
featur
hiv
presenc
protein
spike
envelop
surfac
origin
exist
singl
chain
fusion
protein
newli
made
virus
undergo
proteolyt
process
golgi
complex
intracellular
proteas
produc
two
subunit
distal
domain
membran
span
domain
class
fusion
protein
collect
cooper
action
respons
promot
viral
genom
entri
host
cell
heavili
glycosyl
protein
respons
recognit
bind
viru
host
cell
bind
membran
protein
coreceptor
bind
trigger
conform
chang
ultim
lead
fusion
viral
membran
host
cell
membran
like
class
fusion
protein
made
hydrophob
fusion
peptid
nterminu
ntermin
helic
heptad
repeat
nhr
sequenc
connect
ctermin
helic
heptad
repeat
chr
loop
domain
follow
chr
aromatichydrophob
mper
domain
membran
span
helic
anchor
ctermin
domain
also
contain
membran
interact
sequenc
entri
ntermin
fusion
peptid
becom
expos
like
interact
host
cell
membran
time
nand
ctermin
heptad
repeat
sequenc
undergo
major
transit
nativ
state
extend
helic
conform
heptad
repeat
domain
drive
assembl
elong
bundl
trimer
conform
transit
allow
fusion
peptid
hydrophob
sequenc
mper
destabil
viral
cell
membran
also
bring
membran
close
proxim
ultim
result
mix
viral
cell
membran
creat
passag
releas
viral
genom
cell
qureshi
et
al
show
peptid
name
deriv
loopchelix
heptad
repeat
chr
domain
refer
fusion
initi
region
hypothet
structur
could
block
entri
hiv
cell
discoveri
catalyz
search
peptid
entri
inhibitor
hiv
ultim
led
discoveri
develop
licensur
enfuvirtid
also
known
fuseon
enfuvirtid
peptid
entri
inhibitor
hiv
approv
us
food
drug
administr
fda
european
medicin
agenc
ema
human
use
inject
antivir
peptid
drug
effect
hiv
therapeut
belong
uniqu
class
entri
inhibitor
ad
alreadi
exist
class
includ
revers
transcriptas
inhibitor
hiv
proteas
inhibitor
enfuvirtid
peptid
deriv
amphipath
segment
chr
region
includ
ctermin
end
chr
portion
aromaticamphipath
membran
proxim
ectodomain
region
mper
ctermin
half
enfuvirtid
postfus
structur
fusion
peptid
postfus
state
mper
structur
panel
b
domain
architectur
dengu
viru
famili
flavivirida
envelop
glycoprotein
e
class
ii
vfp
indic
green
domain
yellow
domain
ii
blue
domain
iii
fusion
loop
stem
tm
helic
e
red
indigo
violet
respect
membran
protein
depict
orang
prefus
postfus
structur
panel
c
domain
architectur
vesicular
stomat
viru
famili
rhabdovirida
glycoprotein
g
class
iii
vfp
indic
green
domain
yellow
domain
ii
blue
domain
iii
fusion
loop
stem
tm
helic
g
red
indigo
violet
respect
prefus
structur
postfus
structur
left
portion
panel
b
depict
cellular
viral
membran
modifi
fig
zhang
et
al
rich
aromat
amino
acid
hydrophob
whole
sequenc
strong
propens
form
amphipath
structur
form
postfus
bundl
inhibit
viral
infect
enfuvirtid
vitro
inhibit
entri
although
exact
molecular
mechan
entir
clear
enfuvirtid
may
bind
multipl
region
enfuvirtid
shown
one
studi
inhibit
genom
entri
fusion
step
lipid
mix
taken
place
open
fusion
pore
enfuvirtid
form
stabl
bundl
presenc
nhr
sequenc
unlik
chrderiv
peptid
direct
evid
strong
sequencespecif
bind
enfuvirtid
observ
thu
suggest
interact
transient
fusion
intermedi
state
slightli
differ
variant
bind
strongli
synthet
membran
suggest
inhibit
fusion
pore
format
via
effect
direct
membran
interact
structur
dynam
case
success
enfuvirtid
clinic
difficulttotreat
chronic
viru
demonstr
potenti
util
peptid
entri
inhibitor
viral
therapeut
review
discuss
mani
peptid
entri
inhibitor
envelop
virus
identifi
character
sinc
discoveri
enfuvirtid
connect
hypothes
overlap
mechan
action
prompt
discoveri
character
enfuvirtid
hydrophobicamphipath
peptid
entri
inhibitor
one
us
rfg
taken
recent
year
novel
ration
approach
success
identifi
numer
peptid
entri
inhibitor
envelop
virus
class
class
ii
class
iii
fusion
protein
approach
potenti
peptid
entri
inhibitor
identifi
scan
viral
fusion
protein
sequenc
propens
membran
bind
use
wimleywhit
interfaci
hydrophob
scale
see
next
section
follow
direct
experiment
measur
antivir
activ
small
number
candid
sequenc
identifi
optim
antivir
activ
later
discuss
peptid
entri
inhibitor
studi
show
approach
effect
effici
broadli
generaliz
uniqu
physicalchem
environ
watermembran
interfac
drive
uniqu
class
hydrophob
interact
domin
contribut
aromat
residu
identifi
quantit
interfaci
membranebind
sequenc
peptid
protein
appropri
use
wimleywhit
interfaci
hydrophob
scale
wwih
experimentallydetermin
free
energi
scale
repres
propens
individu
amino
acid
context
peptid
sequenc
partit
water
phosphatidylcholin
interfac
importantli
wwih
base
wholeresidu
free
energi
thu
true
zero
point
distinguish
peptid
sequenc
propens
interact
membran
two
way
wwih
score
use
literatur
review
wwih
use
hydropathi
analysi
mode
calcul
slide
window
hydrophob
score
along
sequenc
protein
approach
identifi
segment
protein
propens
interact
membran
interfac
ii
wwih
use
total
mode
calcul
overal
interfaci
hydrophob
particular
peptid
sequenc
approach
accur
predictor
membran
interact
propens
calcul
wwih
valu
default
low
ph
aspart
glutam
uncharg
histidin
charg
simul
low
ph
environ
endosom
ph
viral
fusion
take
place
support
assumpt
note
pka
valu
acid
group
peptid
molecul
shift
rang
environment
factor
bound
membran
wwih
valu
calcul
assum
random
coil
peptid
partit
bilay
interfac
valu
thu
minimum
possibl
valu
get
favor
peptid
bind
promot
increas
secondari
structur
often
case
possibl
increas
secondari
structur
favor
membran
bind
estim
kcalmolresidu
thu
larg
effect
interfaci
helic
hydrophob
moment
ihhm
anoth
import
physicalchem
factor
relev
membran
interact
secondari
structur
format
peptid
bound
membran
interfac
ihhm
quantifi
degre
peptid
sequenc
would
segreg
hydrophob
hydrophil
face
fold
peptid
larg
ihhm
interact
strongli
membran
helix
due
partitioningfold
coupl
even
wwih
score
posit
overal
although
exact
relationship
partit
fold
extract
quantit
ihhm
provid
use
landmark
shown
tabl
review
show
wwih
score
peptid
includ
ihhm
peptid
entri
inhibitor
valu
larg
enough
potenti
factor
membran
interact
ihhm
wimleywhit
interfaci
hydrophob
scale
score
helic
hydrophob
moment
neutral
low
ph
calcul
use
membran
protein
explor
mpex
web
util
http
blanco
biomoluciedumpex
see
supplement
inform
tutori
use
mpex
util
calcul
wwih
ihhm
initi
proofofconcept
wwihsselect
peptid
function
entri
inhibitor
hrobowski
et
al
identifi
peptid
success
inhibit
flavivirus
dengu
west
nile
classifi
us
nation
institut
allergi
infecti
diseas
niaid
categori
categori
b
prioriti
pathogen
respect
global
health
crisi
caus
dengu
viru
demonstr
critic
import
novel
therapeut
public
health
dengu
vectorborn
viral
diseas
transmit
human
via
infect
aed
aegypti
mosquito
tropic
subtrop
region
recent
expans
temper
climat
global
incid
dengu
increas
past
five
decad
despit
formid
effort
licens
vaccin
approv
therapeut
option
avail
dengu
infect
vari
sever
asymptomat
febril
manifest
potenti
lifethreaten
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
estim
annual
number
infect
worldwid
stand
million
number
may
underreport
annual
number
dh
dss
case
million
estim
death
mainli
among
children
west
nile
viru
also
flaviviru
emerg
spread
west
nile
viru
north
america
particularli
welldocu
exampl
potenti
sudden
emerg
public
health
risk
pose
vector
born
envelop
virus
west
nile
viru
endem
asia
middl
east
australia
howev
west
nile
viru
infect
human
identifi
sever
death
report
queen
new
york
probabl
viru
introduc
infect
bird
anim
viru
spread
rapidli
across
north
america
central
america
rise
identifi
case
death
us
diseas
usual
mild
actual
number
case
may
much
larger
report
number
west
nile
viru
endem
across
north
america
morbid
mortal
west
nile
viru
occur
usual
result
viral
enceph
mening
exampl
illustr
urgent
need
broadspectrum
therapi
envelop
virus
futur
continent
global
pandem
might
caus
envelop
viru
caus
high
morbid
mortal
flavivirus
enter
cell
via
receptor
mediat
endocytosi
intern
endosom
acidif
occur
viral
fusion
protein
e
class
ii
fusion
protein
undergo
major
structur
rearrang
necessari
initi
fusion
viral
cell
membran
find
put
entri
inhibitor
hrobowski
et
al
analyz
fusion
protein
dengu
west
nile
viru
use
wwih
potenti
inhibitor
candid
select
base
posit
wwih
score
fig
show
activ
peptid
select
dengu
west
nile
viru
surfac
glycoprotein
respect
peptid
posit
wwih
test
abil
inhibit
viral
plaqu
format
vitro
peptid
dengu
viru
wwih
ihhm
west
nile
viru
wwih
ihhm
hydrophob
amphipath
prove
effect
dengu
west
nile
virus
respect
ic
valu
around
aromatichydrophob
stem
domain
peptid
studi
lok
et
al
observ
dosedepend
expuls
viral
genom
upon
incub
viru
peptid
indic
direct
virolyt
effect
form
lesion
viral
membran
observ
cryo
transmiss
electron
microscopi
agreement
direct
virolyt
effect
lok
et
al
also
show
moder
membran
partit
free
bound
peptid
observ
posit
interfaci
helic
hydrophob
moment
ihhm
increas
bind
helic
weak
membran
partit
random
coil
peptid
free
peptid
abund
bound
peptid
posit
ihhm
increas
bind
increas
helic
bound
peptid
weak
membran
bind
random
coil
peptid
bound
peptid
difficult
detect
high
helic
hydrophob
moment
ihhm
still
drive
strong
bind
propens
partit
membran
random
coil
high
ihhm
still
drive
strong
membran
bind
signific
interfaci
helic
hydrophob
moment
ihhm
score
signific
nearli
ideal
amphipath
like
bind
strongli
membran
independ
wwih
score
strong
amphipath
strong
membran
bind
high
secondari
structur
content
like
strong
amphipath
strong
enhanc
bind
like
format
structur
like
moder
amphipath
enhanc
membran
bind
helic
like
sequenc
posit
wwih
score
weak
amphipath
littl
effect
bind
structur
determin
wwih
score
bind
strongli
viru
cell
synthet
membran
potent
membran
permeabil
activ
synthet
lipid
vesicl
hand
unlik
vesiclepermeabil
peptid
toxic
effect
mammalian
cell
although
activ
peptid
initi
expect
interact
specif
fusion
protein
observ
nonspecif
membran
interact
consist
physic
chemistrybas
identif
potenti
candid
wwih
schmidt
et
al
studi
seri
close
relat
dengu
viru
stem
domain
peptid
show
peptid
bind
strongli
virus
prior
attach
carri
endosom
along
viru
interestingli
show
incomplet
cross
reactiv
activ
dengu
west
nile
virus
activ
west
nile
viru
dengu
viru
discuss
numer
similar
case
incomplet
crossspeci
inhibit
peptid
entri
inhibitor
sarscov
coronaviru
predominantli
target
respiratori
tract
human
symptom
rang
fever
headach
cough
fatal
respiratori
distress
initi
outbreak
china
sar
cov
infect
least
individu
lead
fatal
high
mortal
rate
sar
elicit
fear
deadli
global
pandem
recent
relat
coronaviru
similarli
high
mortal
call
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
rapid
rise
spread
mer
rais
fear
global
pandem
caus
viru
known
therapeut
coronavirus
envelop
virus
follow
classic
pathway
entri
infect
envelop
virus
surfac
glycoprotein
fusion
protein
viru
call
protein
typic
class
fusion
protein
divid
two
subunit
subunit
respons
bind
viru
host
cell
receptor
subunit
drive
fusion
viral
host
membran
identifi
inhibitori
peptid
sar
cov
sainz
et
al
analyz
subunit
sar
cov
fusion
protein
use
wwih
identifi
five
peptid
sequenc
high
wwih
score
sar
wwi
sar
wwv
fig
hydrophob
sar
wwi
wwih
sequenc
fusion
peptid
peptid
ii
iii
iv
found
outsid
heptadrepeat
sequenc
nand
chelic
heptad
repeat
domain
sar
wwv
correspond
aromaticrich
juxtamembran
domain
analog
stem
domain
obtain
sainz
et
al
show
peptid
five
region
caus
measur
inhibit
viru
infect
sar
wwiii
wwih
sar
wwiv
wwih
show
greatest
inhibit
vitro
ic
sar
wwiii
sar
wwiv
hypothes
inhibit
conform
chang
requir
protein
fusion
although
exact
mechan
action
remain
unknown
paper
sainz
et
al
show
peptid
class
murin
hepat
viru
correspond
hydrophob
segment
sar
wwiv
inhibit
mhv
sar
vitro
ic
howev
equival
sar
peptid
inhibit
mhv
success
use
wimleywhit
interfaci
hydrophob
scale
identifi
peptid
entri
inhibitor
second
pair
virus
differ
class
fusion
protein
class
vs
class
ii
garri
colleagu
demonstr
power
gener
approach
hcmv
doubl
strand
dna
viru
member
herp
viru
famili
hcmv
infect
human
oral
rout
widespread
often
asymptomat
howev
infect
pregnanc
associ
high
morbid
mortal
fetu
similarli
widespread
abund
lead
high
rate
infect
diseas
immunocompromis
patient
lead
retin
blind
hcmv
class
iii
fusion
protein
complex
compos
glycoprotein
gb
gh
gl
glycoprotein
b
gb
primari
role
bind
fusion
viru
host
cell
hcmv
enter
mani
differ
cell
type
use
array
envelop
glycoprotein
conjunct
gb
fusion
entri
often
occur
endocytosi
acidif
also
evid
fusion
neutral
ph
melnik
et
al
identifi
nine
peptid
select
gb
base
propens
membran
partit
per
wwih
fig
four
peptid
wwih
show
inhibit
hcmv
peptid
peptid
also
inhibit
herp
simplex
viru
measl
viru
vesicular
stomat
pseudotyp
viru
author
also
test
effect
peptid
entri
inhibitor
conjug
polycation
tat
cell
penetr
peptid
observ
tat
conjug
increas
antivir
activ
significantli
virus
test
importantli
preincub
cell
tatconjug
peptid
postinfect
treatment
provid
signific
protect
peptid
conjug
tat
measur
inhibit
ad
h
post
infect
tat
conjug
peptid
ic
valu
h
tatcargo
conjug
known
bind
cell
enter
endocytosi
result
suggest
strongli
entri
inhibit
take
place
endosom
compart
readili
access
tatconjug
peptid
possibl
mani
peptid
entri
inhibitor
virtu
propens
membran
bind
enter
endosom
pathway
along
virus
activ
peptid
discov
melnik
et
al
overlap
peptid
identifi
differ
studi
relat
herp
simplex
viru
studi
akkarawongsa
et
al
use
entir
differ
approach
identifi
entri
inhibitor
peptid
class
iii
fusion
protein
hsv
discuss
detail
author
identifi
small
number
inhibitori
peptid
highli
analog
one
identifi
melnik
et
al
likewis
posit
wwih
score
rift
valley
fever
viru
envelop
rna
viru
belong
bunyavirida
famili
rvfv
infect
sometim
accompani
sever
hemorrhag
diseas
fatal
human
livestock
mosquitoborn
viru
endem
part
africa
arabian
peninsula
emerg
signific
public
health
concern
potenti
biothreat
agent
consequ
rvfv
niaid
categori
prioriti
pathogen
highest
possibl
prioriti
g
n
g
c
surfac
glycoprotein
respons
bind
entri
viru
host
cell
g
n
class
ii
fusion
protein
mechan
fusion
rvfv
well
studi
howev
model
use
well
character
fusion
process
class
ii
fusion
protein
identifi
inhibitori
peptid
rvfv
koehler
et
al
identifi
candid
sequenc
g
n
fusion
protein
posit
wwih
score
fig
identifi
region
posit
wwih
score
includ
fusion
loop
peptid
hydrophob
aromat
juxtamembran
stem
domain
stem
domain
peptid
best
activ
author
test
seri
truncat
translat
variant
activ
peptid
wwih
hydrophob
show
inhibit
rvfv
concentr
ic
around
author
show
bind
directli
cell
viru
probabl
inhibit
viral
entri
inhibit
fusion
step
support
somewhat
generaliz
natur
membran
bind
peptid
entri
inhibitor
also
inhibit
envelop
viru
class
fusion
protein
ebola
envelop
viru
class
iii
fusion
protein
vesicular
stomat
viru
howev
inhibit
three
equin
enceph
virus
test
interestingli
one
wwihsposit
peptid
rvfv
g
n
protein
actual
increas
viru
infect
inhibit
peptidedepend
increas
infect
effect
also
observ
screen
variou
membran
bind
peptid
unrel
viral
fusion
protein
lassa
pseudotyp
viru
ar
hoffmann
wc
wimley
rf
garri
unpublish
interfaci
bind
peptid
test
vitro
inhibit
lassa
pseudotyp
viru
five
increas
viru
infect
sometim
twofold
inhibit
given
hypothesi
discuss
perhap
surpris
hydrophob
membraneinteract
peptid
capac
promot
fusion
viral
entri
howev
vast
major
peptid
discuss
literatur
inhibitori
influenza
viru
highli
pathogen
envelop
viru
singl
strand
rna
genom
belong
orthomyxovirida
famili
respons
annual
season
ill
well
occasion
global
pandem
occur
new
strain
aris
recombin
term
morbid
mortal
one
worst
modern
pandem
spanish
flu
outbreak
caus
strain
influenza
viru
kill
much
world
popul
global
recent
identifi
avian
influenza
viru
high
mortal
rate
human
highli
infecti
hand
socal
swine
flu
pandem
infect
global
human
popul
includ
schoolag
children
singl
season
us
center
diseas
control
cdc
estim
peopl
die
pandem
actual
reflect
rel
low
mortal
rate
given
high
infect
rate
everi
annual
flu
season
rais
possibl
highli
infecti
influenza
pandem
also
high
mortal
highlight
urgent
need
broad
spectrum
antivir
therapi
influenza
viru
two
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
play
import
role
entri
viru
host
cell
releas
new
viru
particl
host
cell
respect
ha
first
viral
fusion
protein
character
archetyp
trimer
class
fusion
protein
precursor
activ
proteolyt
cleavag
give
two
subunit
globular
respons
bind
viru
sialic
acid
moieti
protein
lipid
host
cell
surfac
membraneanchor
chain
respons
promot
membran
fusion
upon
bind
viru
intern
clathrin
mediat
endocytosi
late
endosom
stage
acidif
occur
trigger
largescal
conform
chang
nativ
structur
expos
ntermin
fusion
peptid
hydrophob
sequenc
bring
membran
close
proxim
fusion
garri
wilson
colleagu
analyz
fusion
protein
differ
strain
influenza
discov
candid
entri
inhibitor
show
robust
inhibit
viral
plaqu
assay
best
inhibitori
sequenc
fusion
initi
region
fir
compris
hydrophob
segment
nhelic
heptad
repeat
nhr
domain
sever
firderiv
peptid
differ
strain
influenza
character
activ
peptid
name
identifi
fig
show
peptid
sequenc
sever
strain
viru
strain
influenza
wwih
show
maximum
inhibit
viral
plaqu
assay
inhibit
multipl
strain
influenza
b
vivo
ic
valu
current
phase
human
clinic
trial
mechan
action
studi
suggest
entri
inhibitor
despit
fact
interact
measur
influenza
hemagglutinin
neutral
low
ph
h
badani
rw
wilson
rf
garri
wc
wimley
unpublish
pichind
viru
model
arenaviru
famili
includ
multipl
niaid
categori
prioriti
pathogen
includ
lassa
junin
other
therapeut
use
arenavirus
nucleosid
analog
ribavirin
offlabel
use
optim
thu
class
envelop
virus
new
class
inhibitor
arenavirus
desper
need
arenavirus
envelop
glycoprotein
complex
compris
three
protein
chain
receptor
bind
domain
class
fusion
protein
unusu
stabl
signal
peptid
ssp
domain
compris
two
transmembran
helic
connect
loop
spenc
et
al
examin
sequenc
pichind
viru
use
wwih
identifi
peptid
region
posit
wwih
score
fig
five
peptid
inhibitori
activ
pichind
vitro
concentr
b
activ
peptid
correspond
fusion
peptid
somewhat
hydrophob
sequenc
nhelix
heptad
repeat
nhr
domain
strong
propens
form
amphipath
helix
fig
avpp
inhibit
pichind
ic
similarli
inhibit
pseudotyp
virus
envelop
glycoprotein
arenavirus
lassa
junin
machupo
inhibit
vesicular
stomat
herp
simplex
measl
virus
belong
famili
inhibitori
peptid
interact
directli
synthet
viral
membran
interestingli
avpp
significantli
chang
fluiditi
organ
lipid
bind
stabli
measur
fusion
protein
despit
interact
directli
avpp
cryotem
biochem
assay
prematur
trigger
fusioncompet
state
even
neutral
ph
rather
promot
infect
prematur
fusion
compet
inhibitori
consist
propos
critic
role
time
event
product
fusion
import
conclus
work
peptid
interact
directli
viral
membran
chang
physic
properti
way
affect
structur
function
fusion
protein
similar
conclus
drawn
mechan
action
hiv
experi
done
peptid
entri
inhibitor
describ
remain
possibl
mechan
avpp
share
peptid
entri
inhibitor
hepat
c
viru
envelop
rna
viru
flaviviru
famili
transmit
bloodtoblood
contact
share
needl
iv
drug
use
improperli
steril
medic
equip
hepat
c
viru
persist
chronic
mani
infect
peopl
frequent
lead
hepat
liver
cancer
debilit
costli
diseas
high
mortal
fact
death
hcv
us
recent
surpass
caus
hiv
least
sever
hundr
million
peopl
infect
hcv
worldwid
hcv
two
envelop
glycoprotein
transmembran
helic
anchor
form
noncoval
dimer
viral
envelop
individu
role
cell
surfac
bind
fusion
still
entir
clear
propos
fusion
protein
structur
homolog
class
ii
fusion
protein
recent
crystal
structur
show
structur
homolog
known
class
viral
fusion
protein
instead
bioinformat
analys
hcv
protein
suggest
truncat
class
ii
fusion
protein
identifi
hcvinhibit
peptid
sabahi
test
overlap
peptid
also
viroporinlik
protein
liposom
disrupt
liposom
fusion
viral
inhibit
peptid
five
differ
segment
show
signific
activ
liposom
five
region
correspond
region
posit
wwih
score
fig
includ
put
fusion
peptid
aromat
juxtamembran
stemlik
domain
sequenc
propos
fusion
peptid
activ
liposom
posit
wwih
score
therefor
unlik
fusion
peptid
overlap
peptid
test
hcv
pseudoviru
inhibit
assay
four
peptid
identifi
potent
inhibit
concentr
two
antivir
peptid
correspond
region
high
wwih
score
overlap
liposomeact
peptid
fig
two
activ
peptid
small
posit
wwih
score
peptid
activ
pseudotyp
virus
correspond
murin
leukemia
viru
vesicular
stomat
viru
regard
overarch
hypothesi
review
hcv
data
provid
sabahi
et
al
reveal
directli
demonstr
good
overlap
predict
membran
bind
experiment
observ
membran
perturb
antivir
activ
also
show
overlap
incomplet
similar
roughli
correl
posit
wwih
score
entri
inhibit
exampl
describ
also
agre
observ
cross
speci
inhibit
frequent
observ
often
incomplet
conclud
observ
propens
membran
bind
major
contributor
peptid
entri
inhibit
yet
unknown
factor
also
contribut
fig
discoveri
pichind
viru
peptid
entri
inhibitor
use
wwih
protein
fusion
protein
complex
pichind
analyz
use
wwih
identifi
put
membran
interact
sequenc
pichind
gp
structur
current
avail
sequenc
test
identifi
potent
inhibitor
pichind
vitro
peptid
enfuvirtid
mimic
deriv
chelix
heptad
repeat
chr
domain
class
fusion
protein
may
exampl
peptid
entri
inhibitor
act
sequenc
specif
interact
fusion
protein
addit
enfuvirtid
wwih
ihhm
ph
close
relat
wwih
ihhm
peptid
entri
inhibitor
hiv
deriv
chr
domain
one
peptid
call
wwih
ihhm
inhibit
entri
hiv
cell
ic
valu
low
rang
vitro
enfuvirtid
overlap
sequenc
yet
reportedli
sequenc
enabl
interact
specif
pocket
therebi
prevent
conform
chang
requir
fusion
anoth
studi
et
al
began
peptid
chr
region
partial
overlap
enfuvirtid
subsequ
engin
sequenc
ideal
amphipath
helix
assum
would
improv
pharmacolog
properti
vitro
peptid
design
call
wwih
ihhm
ph
potent
entri
inhibitor
mani
strain
hiv
includ
enfuvirtideresist
strain
ic
valu
rang
nm
pm
interact
protein
construct
compris
nhr
sequenc
form
bundl
mimic
nativ
post
fusion
bundl
like
enfuvirtid
shown
function
inhibit
fusion
later
shorter
variant
shown
xray
crystallographi
interact
protein
construct
contain
core
three
helix
bundl
ntermin
heptad
repeat
sequenc
inhibitor
helic
lie
hydrophob
face
hydrophob
groov
nhr
helic
chr
helic
interact
post
fusion
bundl
nativ
addit
studi
author
design
overlap
residu
variant
wwih
ihhm
shown
nm
ic
valu
strain
hiv
test
wwih
score
peptid
neg
neutral
ph
interfaci
helic
hydrophob
moment
extrem
larg
author
made
sequenc
chang
intend
creat
essenti
ideal
amphipath
helic
thu
peptid
propens
bind
membran
hydrophob
surfac
fold
context
central
hypothesi
review
studi
may
reveal
engin
sequenc
highli
activ
multipl
strain
hiv
yet
bear
littl
sequenc
resembl
nativ
sequenc
compar
activ
sequenc
half
residu
chang
dramat
nonconserv
substitut
includ
e
k
l
k
k
e
e
e
e
k
one
sequenc
shown
fold
bundl
nhr
sequenc
despit
nativ
residu
proteinprotein
interfac
suggest
interact
driven
mostli
align
hydrophob
surfac
amphipath
helix
hydrophob
groov
nhr
bundl
instead
highli
sequencespecif
interact
follow
earli
success
enfuvirtid
relat
peptid
hiv
structurebas
approach
use
identifi
entri
inhibitor
envelop
virus
class
fusion
protein
exampl
rapaport
et
al
describ
inhibitori
chr
peptid
fusion
protein
sendai
viru
similarli
lambert
et
al
test
enfuvirtidelik
chr
sequenc
respiratori
syncyti
viru
parainfluenza
viru
measl
viru
report
speciesspecif
inhibit
three
vitro
sub
concentr
lamb
et
al
report
chr
peptid
human
tlymphocyt
leukemia
viru
bovin
leukemia
viru
inhibit
viru
entri
speci
specif
manner
upon
discoveri
identif
sar
coronaviru
sever
group
identifi
chrbase
peptid
entri
inhibitor
sar
class
fusion
protein
use
system
model
similarli
discoveri
fig
discoveri
hepat
c
viru
peptid
entri
inhibitor
three
protein
fusion
protein
complex
hcv
contain
protein
analyz
use
wwih
identifi
put
membran
interact
sequenc
color
segment
plot
peptid
complet
set
overlap
peptid
affect
synthet
membran
blue
inhibit
viru
vitro
red
latter
sequenc
shown
tabl
mer
coronaviru
led
descript
peptid
inhibitor
base
chelix
heptad
repeat
sequenc
mer
protein
author
show
xray
crystallographi
peptid
inhibitor
mer
cocrystal
bundl
mix
construct
contain
ntermin
helic
heptad
repeat
core
avail
data
suggest
variou
chrderiv
peptid
may
inhibit
viru
entri
hydrophob
intermolecular
interact
hydrophob
groov
nhr
segment
class
fusion
protein
whether
sequenc
specif
nativ
like
interact
essenti
activ
certain
case
interact
may
occur
transient
intermedi
structur
like
interfer
structur
function
fusion
protein
critic
event
fusion
chr
entri
inhibitor
bind
stabli
specif
partial
nhr
sequenc
other
appar
despit
evid
chr
peptid
may
act
sequenc
specif
interact
one
univers
featur
common
make
similar
membran
interact
sequenc
describ
elsewher
review
highli
amphipath
ihhm
valu
kcalmol
properti
aris
fact
nativ
structur
pack
hydrophob
groov
nhr
three
helix
core
present
class
fusion
protein
peptid
larg
ihhm
score
like
fold
interact
avail
hydrophob
surfac
enfuvirtid
analog
interact
membran
thu
support
hypothesi
idea
membran
bind
may
import
also
strengthen
observ
inact
enfuvirtid
variant
sever
hydrophob
residu
remov
cterminu
activ
restor
ctermin
addit
octyl
chain
porotto
colleagu
test
set
leash
domain
peptid
influenza
inhibit
influenza
ha
helic
bundl
contain
linear
nonhel
sequenc
similar
chr
sequenc
class
fusion
protein
pack
groov
core
nhelix
bundl
unmodifi
leash
domain
peptid
includ
longest
hydrophob
variant
gtydhdvyrdealnnrfqikgv
elksgykdw
wwih
ihhm
inact
influenza
viru
vitro
author
attach
cholesterol
amino
termini
leash
peptid
modif
hydrophob
cholesterol
effect
tether
peptid
membran
cholesterolmodifi
leash
peptid
found
potent
inhibitor
ec
valu
low
author
show
entri
inhibit
due
inhibit
fusion
multipl
strain
influenza
viru
inhibit
cholesterolconjug
leash
peptid
postul
cholesterol
conjug
insur
peptid
becom
coencapsul
endosom
viru
act
fusion
protein
ph
decreas
main
hypothesi
also
support
multipl
publish
report
peptid
entri
inhibitor
envelop
virus
exampl
brandt
colleagu
describ
accident
discoveri
peptid
broadspectrum
antivir
activ
peptid
call
eb
base
signal
sequenc
initi
design
facilit
cellular
entri
inhibitor
herp
simplex
viru
howev
carrier
peptid
eb
found
potent
viru
inhibitor
pure
form
peptid
ntermin
solubl
sequenc
rrkk
follow
hydrophob
uncharg
residu
sequenc
aavallpavllallap
wwih
propens
membran
interact
eb
inhibit
numer
unrel
virus
includ
herp
simplex
viru
influenza
viru
vaccinia
small
pox
viru
consist
inhibit
depend
peptid
physic
chemistri
rather
sequencespecif
interact
viral
fusion
protein
inhibit
viral
entri
eb
occur
earli
stage
like
inhibit
fusion
brandt
colleagu
show
eb
preincub
protect
cell
viru
show
peptid
bind
enter
cell
also
show
eb
caus
aggreg
virus
variou
protein
driven
hydrophob
ctermin
tail
peptid
remark
similar
narr
nicol
et
al
describ
accident
discoveri
similar
peptid
antiinfluenza
activ
peptid
studi
antiinflammatori
properti
found
direct
antivir
activ
initi
sequenc
call
flupep
wlvffvifyffr
wwih
extrem
hydrophob
peptid
physic
properti
similar
hydrophob
eb
describ
previou
paragraph
author
increas
appar
solubl
flupep
ad
four
ntermin
basic
residu
rrkk
found
peptid
eb
yield
peptid
call
ic
valu
inhibit
variou
influenza
virus
vitro
nm
pm
author
show
inhibit
viru
bind
cell
direct
physic
interact
viru
extrem
hydrophob
like
interact
strongli
cellular
viral
membran
graham
colleagu
also
report
accident
discoveri
potent
antivir
peptid
initi
inform
yeast
analysi
indic
fusion
protein
respiratori
syncyti
viru
rsv
could
interact
rhoa
small
intracellular
gtpase
follow
discoveri
author
identifi
linear
peptid
sequenc
rhoa
respons
interact
ilmcfsidspdslen
wwih
physiolog
relev
interact
fusion
protein
rsv
rhoa
seem
unlik
peptid
nonetheless
found
inhibit
rsv
infect
vitro
peptid
also
inhibit
hiv
subsequ
investig
confirm
viral
inhibit
unrel
put
interact
rhoa
instead
rhoaderiv
peptid
hydrophob
interact
directli
viru
block
cellular
bind
entri
agreement
hypothesi
explor
review
author
conclud
antivir
activ
rhoaderiv
peptid
function
peptid
intrins
biophys
properti
combin
hydrophob
neg
charg
appear
effect
pattern
mani
antivir
molecul
target
rsv
well
mani
envelop
virus
akkarawongsa
et
al
gener
comprehens
set
overlap
peptid
repres
entir
surfac
expos
portion
class
iii
fusion
protein
herp
simplex
viru
whole
set
test
antivir
activ
seven
peptid
identifi
inhibit
hsv
three
peptid
test
insolubl
common
problem
antivir
peptid
discuss
throughout
review
three
activ
peptid
ic
valu
less
vitro
fig
show
structur
wwih
score
protein
posit
seven
inhibitori
peptid
red
strong
support
overarch
hypothesi
membran
interfac
bind
peptid
broadli
inhibit
viral
entri
seven
antivir
peptid
identifi
nonbias
brute
forc
approach
overlap
peak
posit
wwih
score
ctermin
portion
fusion
protein
also
sever
posit
wwih
segment
show
activ
result
consist
success
rate
report
intent
identifi
antivir
peptid
use
wwih
thu
effici
approach
describ
earlier
identifi
candid
base
wwih
test
small
number
candid
directli
activ
valid
work
author
systemat
measur
solubl
antivir
peptid
direct
viral
inactiv
inhibit
cell
bind
inhibit
entri
host
cell
protect
found
peptid
act
mostli
entri
inhibit
small
contribut
direct
viral
inactiv
host
cell
protect
inhibit
cell
bind
observ
similarli
cheng
et
al
use
comprehens
set
overlap
residu
peptid
entir
polyprotein
hepat
c
viru
identifi
peptid
signific
antivir
activ
mani
posit
wwih
score
activ
inhibitori
peptid
call
hydrophob
strong
membran
bind
propens
amphipath
helix
membran
anchor
domain
nonstructur
protein
swlrdiwdwi
cevlsdfk
wwih
ihhm
interact
directli
hepat
c
viral
envelop
virolyt
ec
block
infect
activ
incub
viru
duringprior
initi
entri
stage
interestingli
also
elimin
viru
chronic
infect
cell
suggest
enter
cell
made
lamino
acid
made
damino
acid
biolog
activ
separ
studi
shown
also
potent
activ
hiv
activ
shown
due
direct
disrupt
viral
envelop
integr
studi
also
abl
inhibit
alreadi
establish
hiv
infect
vitro
howev
inhibit
vesicular
stomat
viru
inhibit
nonenvelop
adenoviru
less
amphipath
equal
hydrophob
variant
two
pair
amino
acid
swap
posit
activ
hcv
hiv
permeabil
lipid
vesicl
high
potenc
like
lytic
toxin
consist
high
wwih
score
high
amphipath
howev
unlik
nonspecif
lytic
peptid
eg
melittin
bee
venom
disrupt
cellular
membran
toxic
live
mammalian
cell
low
concentr
hydrophob
secondari
structur
helic
hydrophob
moment
mechan
action
similar
stemderiv
dengu
peptid
describ
importantli
damino
acid
enantiom
activ
lenantiom
show
sequenc
specif
peptideprotein
interact
involv
antivir
activ
li
et
al
made
seri
variant
alter
hydrophob
helic
anti
hcv
antihiv
activ
variant
vitro
remark
similar
variant
studi
two
virus
least
ic
valu
demonstr
entri
inhibit
highli
sequenc
depend
activ
sequenc
chang
abrog
antivir
activ
diminish
interfaci
hydrophob
amphipath
variant
nonpolar
polar
chang
inact
approach
similar
discoveri
si
et
al
test
overlap
amino
acid
peptid
four
protein
thought
import
entri
hepat
c
viru
scaveng
receptor
claudin
occludin
test
peptid
two
overlap
peptid
claudin
potent
inhibitor
hcv
peptid
call
managlqllgfilaflgw
wwih
ihhm
aflgwigaivstalpqwr
wwih
ihhm
uncharg
hydrophob
amphipath
sequenc
fact
sequenc
part
first
membran
span
protein
thu
presum
buri
membran
access
viru
entri
inhibitori
sequenc
block
hcv
pseudoviru
entri
whole
viru
entri
ec
around
also
suppress
establish
hcv
infect
cell
cultur
inhibit
entri
occur
bind
step
effect
peptid
remov
wash
viru
cell
larg
number
translat
truncat
variant
test
half
similar
activ
scrambl
peptid
mostli
inact
damino
acid
peptid
fulli
activ
suggest
sequenc
specif
intermolecular
interact
involv
entri
inhibit
bai
et
al
use
phage
display
identifi
three
peptid
adher
west
nile
viru
fusion
protein
e
two
three
peptid
bound
strongli
fusion
protein
inhibit
viru
vitro
howev
one
peptid
author
call
inhibit
west
nile
viru
vitro
ic
peptid
dtracdviallch
lnt
wwih
hydrophob
two
inact
sequenc
small
posit
wwih
score
seri
truncat
insert
peptid
test
find
sequenc
increas
activ
hydrophob
variant
test
cdvial
lachlnt
wwih
call
also
potent
inhibitor
west
nile
viru
ic
author
also
test
peptid
relat
dengu
viru
fusion
protein
ident
west
nile
viru
interestingli
dengu
opposit
rel
activ
found
highli
activ
activ
final
author
show
inhibit
west
nile
viru
mous
model
brain
involv
decreas
viral
load
increas
surviv
dramat
remark
peptid
appar
abl
cross
blood
brain
barrier
import
properti
therapeut
intend
treat
virus
replic
brain
reil
colleagu
hypothes
long
recogn
inhibit
hiv
patient
coinfect
common
asymptomat
gb
viru
c
relat
hepat
c
due
direct
interact
surfac
glycoprotein
gb
viru
c
class
fusion
protein
hiv
author
examin
peptid
protein
identifi
two
overlap
peptid
wdrgnv
tllcdcpngpwvwv
wwih
ihhm
lcdcpngp
wvwvpafcqavg
wwih
ihhm
inhibit
hiv
vitro
peptid
rich
aromat
residu
hydrophob
amphipath
give
strong
propens
membran
interact
inhibit
hiv
cell
cultur
ic
valu
respect
author
show
two
peptid
inhibit
hiv
entri
earli
step
one
occur
cellsurfac
bind
probabl
fusion
also
show
effect
due
interact
hiv
fusion
protein
alter
conform
rearrang
may
prevent
format
bundl
need
fusion
author
conclud
peptid
specif
bind
interfac
base
competit
bind
assay
weak
sequenc
similar
peptid
hiv
base
fact
physic
chemistri
peptid
similar
mani
peptid
discuss
hypothes
mechan
action
may
includ
nonsequ
specif
interact
peptid
hydrophob
surfac
fusion
proteinmembran
complex
cation
antimicrobi
peptid
constitut
collect
known
peptid
extraordinarili
divers
secondari
tertiari
structur
similar
antibacteri
antifung
activ
amp
found
class
life
critic
part
innat
immun
system
vertebr
invertebr
vertebr
includ
human
produc
mani
differ
amp
broad
spectrum
activ
mani
type
bacteria
unicellular
fungi
activ
amp
bacteria
studi
intens
sinc
discoveri
variat
unifi
mechan
antibacteri
action
emerg
mani
studi
amp
preferenti
bind
anion
plasma
membran
bacteria
gram
posit
gram
neg
virtu
interfaci
activ
disrupt
organ
continu
bacteri
membran
degre
membran
disrupt
increas
sequenti
loss
transmembran
potenti
within
second
leakag
small
molecul
leakag
macromolecul
final
destruct
overal
cellular
architectur
membran
disrupt
natur
amp
aris
fact
amphipath
polar
hydrophob
surfac
hydrophob
surfac
interrupt
polar
cation
residu
describ
interfaci
activ
depend
imperfect
amphipath
antivir
activ
observ
vitro
multipl
amp
propos
evolv
antivir
activ
well
antibacteri
activ
exampl
cation
amphipath
helic
amp
releas
neutrophil
granul
epitheli
cell
broadspectrum
activ
mani
bacteria
pathogen
fungi
recent
report
shown
also
broadspectrum
activ
influenza
virus
vitro
mechan
consist
entri
inhibit
ic
low
rang
inhibit
viruscel
bind
observ
instead
like
antidengu
peptid
discuss
caus
direct
physic
disrupt
viral
membran
favor
wwih
score
overal
interact
membran
fold
hydrophob
face
interfaci
helic
hydrophob
moment
ihhm
neutral
ph
extrem
high
valu
see
tabl
similarli
multipl
class
defensin
cyclic
andor
disulfidecrosslink
cationichydrophob
peptid
also
shown
antivir
activ
hiv
herp
simplex
viru
influenza
viru
sar
coronaviru
inhibit
report
aris
peptideinduc
viral
aggreg
direct
virolyt
effect
doss
et
al
report
studi
collect
synthet
theta
defensin
variant
cyclic
rich
neutrophil
peptid
identifi
sever
sequenc
ic
valu
influenza
viru
less
entri
inhibit
theta
defensin
requir
peptideviru
interact
occur
cell
bind
result
direct
peptideviru
interact
theta
defensin
appar
drive
largescal
aggreg
viral
particl
kumar
colleagu
publish
antivir
peptid
databas
describ
antivir
peptid
cover
possibl
mechan
action
signific
proport
antivir
peptid
entri
inhibitor
class
discuss
review
peptid
entri
inhibitor
describ
initi
expect
inhibit
viral
entri
provid
sequencespecif
competit
inhibit
intermolecular
interact
mostli
involv
viral
fusion
protein
howev
mani
studi
examin
littl
evid
highli
sequenc
specif
interact
evid
provid
class
chrderiv
peptid
mimick
enfuvirtid
instead
strong
evid
gener
activ
peptid
entri
inhibitor
peptid
test
envelop
virus
often
show
least
crossspeci
inhibit
even
unrel
virus
denantiom
show
activ
test
truncat
insert
sequenc
variat
yet
even
without
block
specif
proteinprotein
interact
mani
peptid
effect
inhibit
viru
entri
cell
vitro
ec
valu
sub
nm
low
case
report
inhibit
also
occur
vivo
mechan
action
peptid
entri
inhibitor
studi
multipl
laboratori
peptid
direct
physic
effect
viru
particl
caus
either
physic
disrupt
lipid
bilay
viral
envelop
virolysi
caus
viru
aggreg
shown
bind
affect
synthet
membran
inhibitori
peptid
report
inhibit
bind
virus
cell
attribut
direct
peptid
interact
viru
particl
peptid
seem
act
level
membran
fusion
inhibit
fusion
bound
viru
cell
least
one
case
fusion
inhibit
due
prematur
initi
fusion
protein
conform
peptid
bind
viral
envelop
membran
peptid
entri
inhibitor
bind
directli
cell
interfer
viru
bind
andor
fusion
cell
surfac
may
occur
endocytosi
bound
peptid
viru
mani
studi
suggest
multipl
mechan
play
simultan
hypothes
peptid
propens
membran
bind
due
interfaci
hydrophob
amphipath
interfer
envelop
viru
entri
direct
physic
interact
hydrophob
surfac
membran
fusion
protein
critic
fusion
entri
word
peptid
entri
inhibitor
discuss
share
overlap
mechan
action
deriv
share
physic
chemistri
follow
essenti
peptid
entri
inhibitor
identifi
least
somewhat
hydrophob
andor
amphipath
propens
bind
bilay
membran
interfac
hydrophob
surfac
mani
hydrophob
andor
highli
amphipath
furthermor
mani
acid
isoelectr
point
low
ph
environ
late
endosom
viral
cell
fusion
take
place
trigger
loss
charg
increas
membran
bind
except
antihiv
peptid
hiv
fusion
take
place
neutral
ph
wwih
score
report
reflect
low
ph
membranebound
state
aspart
glutam
effect
uncharg
histidin
charg
known
time
whether
membran
bind
directli
affect
viral
fusion
whether
interact
fusion
protein
absolut
requir
entri
inhibit
howev
note
rapaport
et
al
year
ago
membran
bind
inhibitori
peptid
greatli
increas
effect
concentr
peptid
vicin
fusion
protein
thu
interact
membran
interact
fusion
protein
may
effect
coupl
furthermor
propos
fusion
proteinmembran
complex
expos
hydrophob
surfac
somewhat
variabl
detail
physic
characterist
characterist
includ
size
shape
underli
secondari
structur
expos
hydrophob
patch
well
natur
polar
charg
residu
near
hydrophob
surfac
thu
one
hand
similar
across
class
fusion
protein
give
rise
frequent
crossspeci
inhibit
peptid
entri
inhibitor
hand
variat
physic
detail
expos
hydrophob
surfac
caus
peptid
entri
inhibitor
inact
envelop
virus
may
also
indirect
way
interfaci
bind
peptid
affect
viral
entri
exampl
spike
protein
envelop
virus
crowd
viral
membran
see
fig
may
interact
later
lead
propos
conform
chang
drive
fusion
cooper
event
involv
spike
viru
particl
nearli
simultan
true
cooper
result
later
interact
protein
perhap
includ
tm
domain
thu
membran
physic
properti
could
critic
import
event
drive
viral
entri
possibl
peptid
interfer
function
viral
fusion
protein
chang
physic
chemistri
membran
direct
interact
evid
mechan
discuss
sever
peptid
entri
inhibitor
final
note
similar
physic
chemistri
membran
partit
peptid
membran
transloc
peptid
hydrophob
peptid
partit
membran
also
abl
cross
cell
membran
enter
cell
may
also
cross
endotheli
layer
vivo
perhap
even
includ
blood
brain
barrier
thu
peptid
function
entri
inhibitor
virus
vitro
mechan
propos
may
inher
also
promis
bioavail
characterist
vivo
due
membran
bind
transloc
idea
support
long
half
time
enfuvirtid
human
ten
hour
compar
peptid
minut
support
possibl
shown
directli
peptid
entri
inhibitor
transloc
across
plasma
membran
enter
cell
h
badani
wc
wimley
shown
effect
therapeut
envelop
virus
rare
drug
develop
hiv
influenza
viru
virus
drug
ideal
virus
often
becom
resist
envelop
virus
effect
therapi
thu
entri
inhibit
repres
attract
underutil
target
search
new
therapeut
hypothesi
describ
peptid
entri
inhibitor
act
physic
chemic
interact
hydrophob
surfac
expos
fusion
suggest
novel
approach
discoveri
entri
inhibitor
one
focus
physic
chemistri
put
entri
inhibitor
instead
mostli
brute
forc
structur
base
accident
discoveri
literatur
date
propos
intent
search
novel
hydrophob
amphipath
peptid
entri
inhibitor
base
physic
chemistri
orthogon
select
critic
properti
solubl
ph
sensit
could
result
highli
optim
clinic
effect
peptid
inhibitor
viral
entri
furthermor
sinc
nativelik
specif
intermolecular
interact
probabl
import
entri
inhibitor
made
use
proteas
resist
nonnatur
damino
acid
peptid
use
peptid
mimet
peptidenucl
acid
betapeptid
use
polym
unrel
peptid
